PRKAA1 and non-small cell lung carcinoma: Importantly, we showed for the first time to our knowledge that a sertraline and erlotinib combination induced autophagy in NSCLC, as evidenced by their ability to reciprocally regulate the AMPK/mTOR signaling pathway.